Skip to main content
Signal8

Salzmann Peter

SEC insider (Form 3/4/5 filer). CIK 0001796309. Chief Executive Officer at Immunovant, Inc. (IMVT). 10 reported Form 4/5 transactions since Sep 2024; latest on Apr 16, 2025. Located in NEW YORK, NY.

Companies Salzmann Peter has filed insider reports for

  • Immunovant, Inc. (IMVT): Director, Officer, Chief Executive Officer
Salzmann Peter profile photo

Salzmann Peter

CIK: 0001796309

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (90.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (10.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immunovant, Inc. logo
IMVT

Immunovant, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 16, 2025
    Sale
    Direct
    8.3K shares at avg. $14.89$124K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 9, 2025
    Sale
    Direct
    28.1K shares at avg. $12.99$365K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 1, 2025
    Award
    Direct
    265.8K shares-
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Feb 19, 2025
    Sale
    Direct
    15.4K shares at avg. $20.86$322K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Jan 15, 2025
    Sale
    Direct
    415 shares at avg. $24.19$10K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Jan 15, 2025
    Sale
    Direct
    8.4K shares at avg. $23.81$199K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Jan 8, 2025
    Sale
    Direct
    5.1K shares at avg. $24.10$123K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Nov 20, 2024
    Sale
    Direct
    16.7K shares at avg. $25.45$425K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Oct 16, 2024
    Sale
    Direct
    9.1K shares at avg. $28.79$262K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Oct 9, 2024
    Sale
    Direct
    4.5K shares at avg. $29.56$132K

1-10 of 10